ASX - By Stock
|
RFF |
Re:
Ann: Investor Newsletter
|
|
willbah
|
6 |
3.0K |
1 |
26/06/20 |
26/06/20 |
ASX - By Stock
|
6
|
3.0K
|
1
|
|
ASX - By Stock
|
RFF |
Re:
Ann: Investor Newsletter
|
|
willbah
|
6 |
3.0K |
6 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
6
|
3.0K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
willbah
|
59 |
17K |
1 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
59
|
17K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
willbah
|
124 |
51K |
6 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
124
|
51K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
explain the market cap
|
|
willbah
|
134 |
55K |
2 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
134
|
55K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
explain the market cap
|
|
willbah
|
134 |
55K |
7 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
134
|
55K
|
7
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
willbah
|
124 |
51K |
2 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
124
|
51K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
willbah
|
124 |
51K |
1 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
124
|
51K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
willbah
|
124 |
51K |
2 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
124
|
51K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
willbah
|
124 |
51K |
7 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
124
|
51K
|
7
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
willbah
|
124 |
51K |
2 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
124
|
51K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
willbah
|
124 |
51K |
0 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
124
|
51K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
willbah
|
124 |
51K |
4 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
124
|
51K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
willbah
|
124 |
51K |
2 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
124
|
51K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Global REMAP-CAP Platform Trial Protocol To Include DMX-200
|
|
willbah
|
247 |
78K |
2 |
04/06/20 |
04/06/20 |
ASX - By Stock
|
247
|
78K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Clinical trials discussion
|
|
willbah
|
8 |
3.5K |
2 |
03/06/20 |
03/06/20 |
ASX - By Stock
|
8
|
3.5K
|
2
|
|
ASX - By Stock
|
ALI |
Re:
Ann: App 3Y - Change of Director's Interests - AE Slattery
|
|
willbah
|
2 |
1.1K |
2 |
03/06/20 |
03/06/20 |
ASX - By Stock
|
2
|
1.1K
|
2
|
|
ASX - By Stock
|
LVT |
Re:
Bullish Breakout Incoming
|
|
willbah
|
175 |
92K |
5 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
175
|
92K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Is the calm before the storm
|
|
willbah
|
77 |
20K |
3 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
77
|
20K
|
3
|
|
ASX - By Stock
|
LVT |
Re:
Bullish Breakout Incoming
|
|
willbah
|
175 |
92K |
9 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
175
|
92K
|
9
|
|
ASX - By Stock
|
LVT |
Re:
Bullish Breakout Incoming
|
|
willbah
|
175 |
92K |
8 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
175
|
92K
|
8
|
|
ASX - By Stock
|
DXB |
Re:
Is the calm before the storm
|
|
willbah
|
77 |
20K |
3 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
77
|
20K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Chartwatch - DXB
|
|
willbah
|
350 |
135K |
7 |
26/05/20 |
26/05/20 |
ASX - By Stock
|
350
|
135K
|
7
|
|
ASX - By Stock
|
LVT |
Re:
The second=golden phase for LVT
|
|
willbah
|
53 |
29K |
1 |
26/05/20 |
26/05/20 |
ASX - By Stock
|
53
|
29K
|
1
|
|
ASX - By Stock
|
TYP |
Re:
Buy Recommendation
|
|
willbah
|
82 |
111K |
1 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
82
|
111K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
ChemoCentryx's CCX140 comes up short in rare kidney disorder study
|
|
willbah
|
12 |
2.9K |
0 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
12
|
2.9K
|
0
|
|
ASX - By Stock
|
TYP |
Re:
Buy Recommendation
|
|
willbah
|
82 |
111K |
5 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
82
|
111K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
DMX200 competition including SGLT2 Inhibitors
|
|
willbah
|
30 |
8.7K |
2 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
30
|
8.7K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
DMX200 competition including SGLT2 Inhibitors
|
|
willbah
|
30 |
8.7K |
1 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
30
|
8.7K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
DMX200 competition including SGLT2 Inhibitors
|
|
willbah
|
30 |
8.7K |
3 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
30
|
8.7K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
DMX200 competition including SGLT2 Inhibitors
|
|
willbah
|
30 |
8.7K |
5 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
30
|
8.7K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
DMX200 competition including SGLT2 Inhibitors
|
|
willbah
|
30 |
8.7K |
1 |
17/05/20 |
17/05/20 |
ASX - By Stock
|
30
|
8.7K
|
1
|
|
ASX - By Stock
|
AFI |
Re:
Ann: Appendix 3Y - Change of Director's Interest Notice
|
|
willbah
|
2 |
2.4K |
2 |
15/05/20 |
15/05/20 |
ASX - By Stock
|
2
|
2.4K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
1 year Price target?
|
|
willbah
|
43 |
22K |
0 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
43
|
22K
|
0
|
|
ASX - By Stock
|
MX1 |
Re:
Hardly glory...
|
|
willbah
|
8 |
2.7K |
2 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
8
|
2.7K
|
2
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: Micro-X Results of Entitlement Offer
|
|
willbah
|
3 |
1.4K |
0 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
3
|
1.4K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
What matters most? Acuity or Duration? What if Opthea was wrong?
|
|
willbah
|
16 |
8.0K |
8 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
16
|
8.0K
|
8
|
|
ASX - By Stock
|
AFI |
Re:
Ann: NTA & Top 25 Investments as at 30 April 2020
|
|
willbah
|
3 |
3.3K |
2 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
3
|
3.3K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor Presentation
|
|
willbah
|
1 |
1.1K |
1 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
1
|
1.1K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Heads up: OPT is about to skyrocket
|
|
willbah
|
46 |
24K |
0 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
46
|
24K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Heads up: OPT is about to skyrocket
|
|
willbah
|
46 |
24K |
2 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
46
|
24K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Heads up: OPT is about to skyrocket
|
|
willbah
|
46 |
24K |
2 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
46
|
24K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Heads up: OPT is about to skyrocket
|
|
willbah
|
46 |
24K |
1 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
46
|
24K
|
1
|
|
ASX - By Stock
|
ALX |
Re:
Ann: Toll Revenue, Traffic Statistics & Liquidity Update Q1 2020
|
|
willbah
|
2 |
1.5K |
0 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
2
|
1.5K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Industry Mag
|
|
willbah
|
27 |
9.4K |
5 |
21/04/20 |
21/04/20 |
ASX - By Stock
|
27
|
9.4K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Industry Mag
|
|
willbah
|
27 |
9.4K |
0 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
27
|
9.4K
|
0
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: Commences Federal Court Action against ASX
|
|
willbah
|
2.7K |
1.2M |
3 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
2.7K
|
1.2M
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Heads up: OPT is about to skyrocket
|
|
willbah
|
46 |
24K |
0 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
46
|
24K
|
0
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: Trading Halt
|
|
willbah
|
36 |
12K |
1 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
36
|
12K
|
1
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: Trading Halt
|
|
willbah
|
36 |
12K |
2 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
36
|
12K
|
2
|
|